Table 4 HPV-capsid antibodies in subgroups of HIV-positive men
VLP-type | 6 | 11 | 16 | 18 | 31 | cumulative | cumulative |
|---|---|---|---|---|---|---|---|
low risk (6, 11) | high risk (16, 18, 31) | ||||||
all men (n = 168) | 19% | 16% | 30% | 20% | 20% | 24% | 41% |
homosexuals with warts (n = 9) | 55% | 44% | 67% | 33% | 67% | 67% | 89% |
homosexuals without warts (n = 50) | 22% | 14% | 30% | 26% | 26% | 30% | 42% |
heterosexuals with warts (n = 16) | 19% | 19% | 44% | 19% | 12% | 25% | 50% |
heterosexuals without warts (n = 93) | 12% | 14% | 19% | 12% | 13% | 16% | 31% |
drug users (n = 60) | 12% | 8% | 18% | 8% | 13% | 13% | 28% |